Skip to content

    Recently Viewed

      Listening...

      Home / Media Center / Press releases / Financial /
      Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results

      Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results

      Share Article
      share to

      New Brunswick, NJ (March 11, 2014) - Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 15th, to review first-quarter results. Dominic Caruso, Vice President, Finance and Chief Financial Officer and Louise Mehrotra, Vice President, Investor Relations, will host the call.

      Investors and other interested parties may access the conference call in the following ways:

      • At Johnson & Johnson’s website: www.investor.jnj.com. This earnings webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads. A webcast and podcast replay will be available approximately two hours after the conference call concludes.
      • By telephone: For both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 855-453-3829. For participants outside the U.S., the dial-in number is 970-315-3906. The conference ID number for all callers is 10490090. A replay of the conference call will be available beginning at approximately 12:00 p.m. on April 15, 2014, and ending at approximately 12:00 a.m. on April 22, 2014. The replay dial-in number for U.S. participants is 855-859-2056. For participants outside the U.S., the replay dial-in number is 404-537-3406. The replay conference ID number for all callers is 10490090.

      About Johnson & Johnson
      Caring for the world, one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 128,000 employees at more than 275 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

      ###

      Press Contacts:
      Ernie Knewitz
      (732) 524-6623
      (917) 697-2318 (M)

      Investor Contacts:
      Louise Mehrotra
      (732) 524-6491

      Stan Panasewicz
      (732) 524-2524

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.